Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Mesangial Deposition Can Strongly Involve Innate-Like IgA Molecules Lacking Affinity Maturation.

Wehbi B, Oblet C, Boyer F, Huard A, Druilhe A, Paraf F, Cogné E, Moreau J, El Makhour Y, Badran B, Van Egmond M, Cogné M, Aldigier JC.

J Am Soc Nephrol. 2019 Jul;30(7):1238-1249. doi: 10.1681/ASN.2018111089. Epub 2019 Jun 21.

PMID:
31227634
2.

Locus suicide recombination actively occurs on the functionally rearranged IgH allele in B-cells from inflamed human lymphoid tissues.

Dalloul I, Boyer F, Dalloul Z, Pignarre A, Caron G, Fest T, Chatonnet F, Delaloy C, Durandy A, Jeannet R, Lereclus E, Boutouil H, Aldigier JC, Péron S, Le Noir S, Cook-Moreau J, Cogné M.

PLoS Genet. 2019 Jun 14;15(6):e1007721. doi: 10.1371/journal.pgen.1007721. eCollection 2019 Jun.

3.

G-quadruplex DNA targeting alters class-switch recombination in B cells and attenuates allergic inflammation.

Dalloul Z, Chenuet P, Dalloul I, Boyer F, Aldigier JC, Laffleur B, El Makhour Y, Ryffel B, Quesniaux VFJ, Togbé D, Mergny JL, Cook-Moreau J, Cogné M.

J Allergy Clin Immunol. 2018 Oct;142(4):1352-1355. doi: 10.1016/j.jaci.2018.06.011. Epub 2018 Jun 20. No abstract available.

PMID:
29935221
4.

Detecting Rare AID-Induced Mutations in B-Lineage Oncogenes from High-Throughput Sequencing Data Using the Detection of Minor Variants by Error Correction Method.

Martin OA, Garot A, Le Noir S, Aldigier JC, Cogné M, Pinaud E, Boyer F.

J Immunol. 2018 Aug 1;201(3):950-956. doi: 10.4049/jimmunol.1800203. Epub 2018 Jun 13.

5.

CSReport: A New Computational Tool Designed for Automatic Analysis of Class Switch Recombination Junctions Sequenced by High-Throughput Sequencing.

Boyer F, Boutouil H, Dalloul I, Dalloul Z, Cook-Moreau J, Aldigier JC, Carrion C, Herve B, Scaon E, Cogné M, Péron S.

J Immunol. 2017 May 15;198(10):4148-4155. doi: 10.4049/jimmunol.1601924. Epub 2017 Apr 17.

6.

IgA Structure Variations Associate with Immune Stimulations and IgA Mesangial Deposition.

Oruc Z, Oblet C, Boumediene A, Druilhe A, Pascal V, Le Rumeur E, Cuvillier A, El Hamel C, Lecardeur S, Leanderson T, Morelle W, Demengeot J, Aldigier JC, Cogné M.

J Am Soc Nephrol. 2016 Sep;27(9):2748-61. doi: 10.1681/ASN.2015080911. Epub 2016 Jan 29.

7.

Minimization of maintenance immunosuppressive therapy after renal transplantation comparing cyclosporine A/azathioprine or cyclosporine A/mycophenolate mofetil bitherapy to cyclosporine A monotherapy: a 10-year postrandomization follow-up study.

Thierry A, Le Meur Y, Ecotière L, Abou-Ayache R, Etienne I, Laurent C, Vuiblet V, Colosio C, Bouvier N, Aldigier JC, Rerolle JP, Javaugue V, Gand E, Bridoux F, Essig M, Hurault de Ligny B, Touchard G.

Transpl Int. 2016 Jan;29(1):23-33. doi: 10.1111/tri.12627. Erratum in: Transpl Int. 2016 Jul;29(7):833. Lemeur, Yann [corrected to Le Meur, Yannick].

8.

A Familial C3GN Secondary to Defective C3 Regulation by Complement Receptor 1 and Complement Factor H.

Chauvet S, Roumenina LT, Bruneau S, Marinozzi MC, Rybkine T, Schramm EC, Java A, Atkinson JP, Aldigier JC, Bridoux F, Touchard G, Fremeaux-Bacchi V.

J Am Soc Nephrol. 2016 Jun;27(6):1665-77. doi: 10.1681/ASN.2015040348. Epub 2015 Oct 15.

9.

Development of a risk stratification algorithm to improve patient-centered care and decision making for incident elderly patients with end-stage renal disease.

Couchoud CG, Beuscart JB, Aldigier JC, Brunet PJ, Moranne OP; REIN registry.

Kidney Int. 2015 Nov;88(5):1178-86. doi: 10.1038/ki.2015.245. Epub 2015 Sep 2.

PMID:
26331408
10.

The clinical status and survival in elderly dialysis: example of the oldest region of France.

Glaudet F, Hottelart C, Allard J, Allot V, Bocquentin F, Boudet R, Champtiaux B, Charmes JP, Ciobotaru M, Dickson Z, Essig M, Honoré P, Lacour C, Lagarde C, Manescu M, Peyronnet P, Poux JM, Rerolle JP, Rincé M, Couchoud C, Aldigier JC; REIN Limousin.

BMC Nephrol. 2013 Jun 25;14:131. doi: 10.1186/1471-2369-14-131.

11.

Impact of prior CKD management in a renal care network on early outcomes in incident dialysis patients: a prospective observational study.

Rognant N, Alamartine E, Aldigier JC, Combe C, Vendrely B, Deteix P, Cluzel P, Juillard L, Vrtovsnik F, Maurice C, Fave S, Laville M.

BMC Nephrol. 2013 Feb 20;14:41. doi: 10.1186/1471-2369-14-41.

12.

Specific impairment of proximal tubular cell proliferation by a monoclonal κ light chain responsible for Fanconi syndrome.

El Hamel C, Aldigier JC, Oblet C, Laffleur B, Bridoux F, Cogné M.

Nephrol Dial Transplant. 2012 Dec;27(12):4368-77. doi: 10.1093/ndt/gfs261. Epub 2012 Sep 28.

PMID:
23024220
13.

Bordetella holmesii bacteremia in a renal transplant recipient: emergence of a new pathogen.

Chambaraud T, Dickson Z, Ensergueix G, Barraud O, Essig M, Lacour C, Allard J, Bocquentin F, Aldigier JC, Rerolle JP.

Transpl Infect Dis. 2012 Dec;14(6):E134-6. doi: 10.1111/tid.12009. Epub 2012 Sep 24.

PMID:
22998023
14.

Gammopathy with IgA mesangial deposition provides a monoclonal model of IgA nephritogenicity and offers new insights into its molecular mechanisms.

Boumediene A, Oblet C, Oruc Z, Duchez S, Morelle W, Huynh A, Pourrat J, Aldigier JC, Cogné M.

Nephrol Dial Transplant. 2011 Dec;26(12):3930-7. doi: 10.1093/ndt/gfr131. Epub 2011 Mar 31.

PMID:
21459784
15.

Severe sirolimus-induced acute hepatitis in a renal transplant recipient.

Jacques J, Dickson Z, Carrier P, Essig M, Guillaudeau A, Lacour C, Bocquentin F, Aldigier JC, Rerolle JP.

Transpl Int. 2010 Sep;23(9):967-70. doi: 10.1111/j.1432-2277.2010.01100.x. Epub 2010 May 20.

16.

Crystal-storing histiocytosis with renal Fanconi syndrome: pathological and molecular characteristics compared with classical myeloma-associated Fanconi syndrome.

El Hamel C, Thierry A, Trouillas P, Bridoux F, Carrion C, Quellard N, Goujon JM, Aldigier JC, Gombert JM, Cogné M, Touchard G.

Nephrol Dial Transplant. 2010 Sep;25(9):2982-90. doi: 10.1093/ndt/gfq129. Epub 2010 Mar 31.

PMID:
20356978
17.

C.E.R.A. safety profile: a pooled analysis in patients with chronic kidney disease.

Locatelli F, Mann JF, Aldigier JC, Sanz Guajardo D, Schmidt R, Van Vlem B, Sulowicz W, Dougherty FC, Beyer U.

Clin Nephrol. 2010 Feb;73(2):94-103.

PMID:
20129016
18.

Equity of accessibility to dialysis facilities.

Richard JB, Aldigier JC, Le Mignot L, Glaudet F, Ben Said M, Landais P.

Stud Health Technol Inform. 2009;150:777-81.

PMID:
19745417
19.

A renal transplant recipient with intraglomerular Candida albicans.

Dickson Z, Bocquentin F, Essig M, Paraf F, Aldigier JC, Rérolle JP.

NDT Plus. 2009 Aug;2(4):329-30. doi: 10.1093/ndtplus/sfp051. Epub 2009 Apr 23. No abstract available.

20.

An unusual pulmonary complication of cytomegalovirus infection in a renal transplant recipient.

Jacques J, Dallocchio A, Dickson Z, Bocquentin F, Jebali H, Aldigier JC, Essig M, Rerolle JP.

NDT Plus. 2008 Aug;1(4):236-8. doi: 10.1093/ndtplus/sfn055. Epub 2008 May 21. No abstract available.

21.

PAI-1 donor polymorphism influences long-term kidney graft survival.

Rérolle JP, Munteanu E, Drouet M, Szelag JC, Champtiaux B, Yagoubi F, Preux PM, Aldigier JC, Le Meur Y.

Nephrol Dial Transplant. 2008 Oct;23(10):3325-32. doi: 10.1093/ndt/gfn241. Epub 2008 May 7.

PMID:
18463321
22.

Protection of Renal Function with ACE Inhibitors: Experience with Benazepril.

Aldigier JC, Meur YL, Brunel P.

Clin Drug Investig. 1998;16(6):463-72.

PMID:
18370561
23.

Diagnosis of left ventricular diastolic dysfunction in the setting of acute changes in loading conditions.

Vignon P, Allot V, Lesage J, Martaillé JF, Aldigier JC, François B, Gastinne H.

Crit Care. 2007;11(2):R43.

24.

Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan.

Pool JL, Schmieder RE, Azizi M, Aldigier JC, Januszewicz A, Zidek W, Chiang Y, Satlin A.

Am J Hypertens. 2007 Jan;20(1):11-20.

PMID:
17198906
25.

[Renal transplantation in the elderly: a survey].

Rerolle JP, Szelag JC, Diaconita M, Saada F, Aldigier JC, Le Meur Y.

Nephrol Ther. 2006 Feb;2(1):8-14. Epub 2006 Feb 17. French.

PMID:
16895710
26.

Role of the monoclonal kappa chain V domain and reversibility of renal damage in a transgenic model of acquired Fanconi syndrome.

Sirac C, Bridoux F, Carrion C, Devuyst O, Fernandez B, Goujon JM, El Hamel C, Aldigier JC, Touchard G, Cogné M.

Blood. 2006 Jul 15;108(2):536-43. Epub 2006 Mar 16.

27.

Intracranial granuloma and skull osteolysis: complication of a primary cutaneous cryptococcosis in a kidney transplant recipient.

Rerolle JP, Szelag JC, Diaconita M, Paraf F, Aldigier JC, Le Meur Y.

Am J Kidney Dis. 2005 Dec;46(6):e113-7.

PMID:
16310562
28.

The renal epidemiology and information network (REIN): a new registry for end-stage renal disease in France.

Couchoud C, Stengel B, Landais P, Aldigier JC, de Cornelissen F, Dabot C, Maheut H, Joyeux V, Kessler M, Labeeuw M, Isnard H, Jacquelinet C.

Nephrol Dial Transplant. 2006 Feb;21(2):411-8. Epub 2005 Oct 18.

PMID:
16234286
29.

Regression of existing glomerulosclerosis by inhibition of aldosterone.

Aldigier JC, Kanjanbuch T, Ma LJ, Brown NJ, Fogo AB.

J Am Soc Nephrol. 2005 Nov;16(11):3306-14. Epub 2005 Sep 28.

30.

Regression of glomerulosclerosis with high-dose angiotensin inhibition is linked to decreased plasminogen activator inhibitor-1.

Ma LJ, Nakamura S, Aldigier JC, Rossini M, Yang H, Liang X, Nakamura I, Marcantoni C, Fogo AB.

J Am Soc Nephrol. 2005 Apr;16(4):966-76. Epub 2005 Feb 23.

31.

When the kidney catches a cold: an unusual cause of acute renal failure.

Hottelart C, Diaconita M, Champtiaux B, Soulis F, Aldigier JC.

Nephrol Dial Transplant. 2004 Sep;19(9):2421-2. No abstract available.

PMID:
15299112
32.

Serum levels of macrophage-colony stimulating factor (M-CSF): a marker of kidney allograft rejection.

Le Meur Y, Leprivey-Lorgeot V, Mons S, José M, Dantal J, Lemauff B, Aldigier JC, Leroux-Robert C, Praloran V.

Nephrol Dial Transplant. 2004 Jul;19(7):1862-5. Epub 2004 May 18.

PMID:
15150350
33.

Molecular study of an IgG1kappa cryoglobulin yielding organized microtubular deposits and glomerulonephritis in the course of chronic lymphocytic leukaemia.

Galea HR, Bridoux F, Aldigier JC, Paraf F, Bordessoule D, Touchard G, Cogné M.

Clin Exp Immunol. 2002 Jul;129(1):113-8.

34.

[Exploring AT(1) and AT(2) angiotensin II receptors in humans].

Aldigier JC, Ghannad E.

Drugs. 2002;62 Spec No 1:11-9. Review. French.

PMID:
12036385
35.

Analysis of three genetic markers in IgA nephropathy patients from a single region.

Drouet M, Aupetit C, Denizot Y, Bois M, Bridoux F, Aldigier JC, Cogné M.

Clin Nephrol. 2002 Apr;57(4):253-60. Review.

PMID:
12005241
36.

Restenotic process and DD genotype after angiotensin-converting enzyme inhibitor treatment.

Achard JM, Leborgne L, Tribouilloy C, Aldigier JC, Fournier A.

Lancet. 2001 Sep 1;358(9283):757-8; author reply 758-9. No abstract available.

PMID:
11556340
37.

Plasma levels and metabolism of AcSDKP in patients with chronic renal failure: relationship with erythropoietin requirements.

Le Meur Y, Lorgeot V, Comte L, Szelag JC, Aldigier JC, Leroux-Robert C, Praloran V.

Am J Kidney Dis. 2001 Sep;38(3):510-7.

PMID:
11532682
38.

Polymorphism of the human alpha1 immunoglobulin gene 3' enhancer hs1,2 and its relation to gene expression.

Denizot Y, Pinaud E, Aupetit C, Le Morvan C, Magnoux E, Aldigier JC, Cogné M.

Immunology. 2001 May;103(1):35-40.

39.

INSIGHT and NORDIL. International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment. Nordic Diltiazem Study.

Achard JM, Oudart N, Aldigier JC.

Lancet. 2000 Dec 2;356(9245):1926-7; author reply 1928-9. No abstract available.

PMID:
11130401
40.

Deregulated platelet-activating factor levels and acetylhydrolase activity in patients with idiopathic IgA nephropathy.

Denizot Y, Aupetit C, Bridoux F, Alphonse JC, Cogné M, Aldigier JC.

Nephrol Dial Transplant. 2000 Sep;15(9):1344-7.

PMID:
10978389
41.

Alleles of the alpha1 immunoglobulin gene 3' enhancer control evolution of IgA nephropathy toward renal failure.

Aupetit C, Drouet M, Pinaud E, Denizot Y, Aldigier JC, Bridoux F, Cogné M.

Kidney Int. 2000 Sep;58(3):966-71.

42.
43.

Whole blood production of monocytic cytokines (IL-1beta, IL-6, TNF-alpha, sIL-6R, IL-1Ra) in haemodialysed patients.

Le Meur Y, Lorgeot V, Aldigier JC, Wijdenes J, Leroux-Robert C, Praloran V.

Nephrol Dial Transplant. 1999 Oct;14(10):2420-6.

PMID:
10528667
44.

Regulation of erythropoiesis by bone marrow reninangiotensin system: facts and speculations.

Praloran V, Comte L, Le Meur Y, Aldigier JC.

Exp Hematol. 1998 Oct;26(11):1020-1. No abstract available.

PMID:
9766440
45.

Acute renal failure in a marathon runner: role of glomerular bleeding in tubular injury.

Le Meur Y, Paraf F, Szelag JC, Aldigier JC, Leroux-Robert C.

Am J Med. 1998 Sep;105(3):251-2. No abstract available.

PMID:
9753030
46.

Is plasma Ac-SDKP level a reliable marker of chronic angiotensin-converting enzyme inhibition in hypertensive patients?

Le Meur Y, Aldigier JC, Praloran V.

Hypertension. 1998 May;31(5):1201-2. No abstract available.

PMID:
9576137
47.

M-CSF serous rate evolution during post-transplantation days in a heterotopic heart graft model mice.

Cornu E, Lacroix P, Virot P, Aldigier JC, Praloran P, Christides C, Laskar M.

J Cardiovasc Surg (Torino). 1997 Dec;38(6):567-70.

PMID:
9461259
48.

Effects of the angiotensin-converting enzyme inhibitor enalapril on blood haematopoietic progenitors and acetyl-N-Ser-Asp-Lys-Pro concentrations.

Comte L, Lorgeot V, Volkov L, Allegraud A, Aldigier JC, Praloran V.

Eur J Clin Invest. 1997 Sep;27(9):788-90.

PMID:
9352252
49.

Macrophage colony stimulating factor involvement in uremic patients.

Le Meur Y, Fixe P, Aldigier JC, Leroux-Robert C, Praloran V.

Kidney Int. 1996 Sep;50(3):1007-12.

50.

PAF and hematopoiesis. VIII. Biosynthesis and metabolism of PAF by human bone marrow stromal cells.

Denizot Y, Rougier F, Dupuis F, Verger C, Dulery C, Laskar M, Aldigier JC, Praloran V.

Exp Hematol. 1996 Sep;24(11):1327-32.

PMID:
8862444

Supplemental Content

Loading ...
Support Center